S100A9与基质金属蛋白酶9在消化系统恶性肿瘤中的研究进展(5)
[25]Xu Y，Li Z，Jiang P，et al.The co-expression of MMP-9 and Tenascin-C is significantly associated with the progression and prognosis of pancreatic cancer[J].Diagn Pathol，2015，10：211.
[26]Omran OM，Thabet M.Gelatinases A and B expression in human colorectal cancer in upper Egypt： a clinicopathological study[J].Ultrastruct Pathol，2012，36(2)：108-116.
[27]Sakamoto Y，Mafune K，Mori M，et al.Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma[J].Int J Oncol，2000，17(2)：237-243.
[28]Chen R，Cui J，Xu C，et al.The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection[J].Ann Surg Oncol，2012，19 Suppl 3：S375-384.
[29]周志鹏，于牧川，谭向龙，等.MMP诱导因子CD147和MMP-9在胆囊癌组织中的表达及其意义[J].中国现代普通外科进展，2016，19(7)：543-546.
[30]张晶锐，高峰，李荣江.HSP90α、MMP-9在胆管癌组织中的表达及其临床意义[J].中国临床研究，2017，30(8) 1067-1069.
[31]Ghosh S，Basu M，Roy SS.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3[J].J Biol Chem，2012， 287(18)：15001-15015.
[32]Bausch D，Pausch T，Krauss T，et al.Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma[J].Angiogenesis，2011，14(3)：235-243.
[33]Hibino T，Sakaguchi M，Miyamoto S，et al.S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis[J].Cancer Res，2013，73(1)：172-183.
[34]Lim SY，Yuzhalin AE，Gordon-Weeks AN，et al.Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells[J].Oncogene，2016，35(44)：5735-5745.
[35]Kessenbrock K，Plaks V，Werb Z.Matrix metalloproteinases：regulators of the tumor microenvironment[J].Cell，2010， 141(1)：52-67.
(收稿日期：2019-01-21 本文編辑：祁海文), 百拇医药(潘井岗 肖卫东)
[26]Omran OM，Thabet M.Gelatinases A and B expression in human colorectal cancer in upper Egypt： a clinicopathological study[J].Ultrastruct Pathol，2012，36(2)：108-116.
[27]Sakamoto Y，Mafune K，Mori M，et al.Overexpression of MMP-9 correlates with growth of small hepatocellular carcinoma[J].Int J Oncol，2000，17(2)：237-243.
[28]Chen R，Cui J，Xu C，et al.The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection[J].Ann Surg Oncol，2012，19 Suppl 3：S375-384.
[29]周志鹏，于牧川，谭向龙，等.MMP诱导因子CD147和MMP-9在胆囊癌组织中的表达及其意义[J].中国现代普通外科进展，2016，19(7)：543-546.
[30]张晶锐，高峰，李荣江.HSP90α、MMP-9在胆管癌组织中的表达及其临床意义[J].中国临床研究，2017，30(8) 1067-1069.
[31]Ghosh S，Basu M，Roy SS.ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3[J].J Biol Chem，2012， 287(18)：15001-15015.
[32]Bausch D，Pausch T，Krauss T，et al.Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma[J].Angiogenesis，2011，14(3)：235-243.
[33]Hibino T，Sakaguchi M，Miyamoto S，et al.S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis[J].Cancer Res，2013，73(1)：172-183.
[34]Lim SY，Yuzhalin AE，Gordon-Weeks AN，et al.Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells[J].Oncogene，2016，35(44)：5735-5745.
[35]Kessenbrock K，Plaks V，Werb Z.Matrix metalloproteinases：regulators of the tumor microenvironment[J].Cell，2010， 141(1)：52-67.
(收稿日期：2019-01-21 本文編辑：祁海文), 百拇医药(潘井岗 肖卫东)